Todays top RNS's: Greatland Gold PLC, Atlas Metals Group, Hemogenyx Pharma Plc and more

Greatland Gold PLC - Results of RetailBook Offer

Greatland Resources Limited - Results of RetailBook Offer

Greatland Resources has successfully secured £6,686,165 through a retail offer of new ordinary shares, receiving significant demand. The shares, priced at 316 pence, are set to be admitted to the London Stock Exchange's AIM Market and the ASX. Completion is contingent on UK Court sanctioning.

Atlas Metals Group - Proposed Acquisition of UPSA and Corporate Update

Atlas Metals Group PLC: Proposed Acquisition of Universal Pozzolanic Silica Alumina Ltd and Corporate Update

Atlas Metals Group PLC announces a non-binding Letter of Intent to acquire Universal Pozzolanic Silica Alumina Ltd through a share-for-share exchange. This strategic acquisition aims to leverage substantial PSA reserves for greener concrete production. Additionally, Atlas is divesting non-core assets, including the Gold Ridge asset in Arizona, to align with its growth strategy.

Hemogenyx Pharma Plc - Clearance to Proceed with Pediatric Expansion

Regulatory Clearance to Proceed with Pediatric Expansion of HG-CT-1 Clinical Trial

Hemogenyx Pharmaceuticals plc (LSE: HEMO) has received regulatory clearance from the FDA to initiate pediatric enrolment in its Phase I trial of HG-CT-1, a CAR-T therapy for relapsed/refractory acute myeloid leukemia. This milestone marks a significant step towards offering innovative therapies to children and adolescents battling this challenging disease.

ITM Power PLC - Selected for two UK projects

ITM Power PLC Selected for Two UK Projects

ITM Power has been chosen as the supplier for two UK green hydrogen projects, including one secured under the UK government's Hydrogen Allocation Round 2 (HAR2). The projects will deploy ITM's POSEIDON electrolysis technology to provide green hydrogen for local industries, aiming to reduce carbon emissions. Both projects await Final Investment Decision approval.

Legal & General Grp - L&G Deep Dive: Asset Management

L&G Investor Deep Dive: Asset Management

Legal & General Group Plc (L&G) is hosting an Investor Deep Dive focused on its Asset Management business, emphasizing its position as a core growth engine. They present strategies for profitable growth, targeting increased fee-related earnings and expansion in Private Markets. L&G aims for significant operating profit growth by 2028, leveraging synergistic business model strengths.

Vinanz Limited - Fundraise Total Lifted to £3.579 million

Fundraise Total Lifted to £3.579 million

Vinanz Limited, a Bitcoin treasury and mining company listed on the London Stock Exchange, has increased its fundraising total to £3.579 million. This includes £550,000 from direct subscriptions at 13.75 pence per share, alongside £3.029 million from a Retail Offer. The new shares will be admitted for trading around 24 June 2025.

Warpaint London PLC - AGM Statement

AGM Statement

Warpaint London PLC anticipates strong sales growth, with revenues for the first half of 2025 projected between £50 million and £52 million. Despite a US slowdown due to higher tariffs, margins have improved. The acquisition of Brand Architekts offers new growth opportunities. The Group maintains a robust financial position and remains on track to meet annual market expectations.

Andrada Mining Ltd - Andrada Secures High-Grade Tin Feedstock

Andrada Secures High-Grade Tin Feedstock

Andrada Mining Limited has finalized a significant agreement to secure high-grade tin ore from Goantagab, Namibia. This supply will enhance production at the Uis processing facility. The collaboration includes a profit-sharing agreement and an accelerated ramp-up plan with an independent contractor, Birca Mining. The initiative bolsters Andrada's strategic position in critical mineral production.

Angle PLC - EACR 2025: Data demonstrating DNA dual analysis

ANGLE presents new data at EACR 2025 Demonstrating DNA Dual Analysis for Comprehensive Liquid Biopsy Profiling

ANGLE plc revealed its research at the EACR 2025 Congress in Lisbon. Using ANGLE's Parsortix® system, the study demonstrates a unique workflow integrating CTC-DNA and ctDNA analysis, offering insights into tumor heterogeneity in lung cancer patients, potentially enhancing drug development and patient stratification from a single blood sample. For Research Use Only.

Mila Resources Plc - Placing to Accelerate Yarrol Exploration

Conditional Placing of £756,000 to accelerate exploration at Yarrol

Mila Resources Plc (LSE:MILA) has raised approximately £756,000 through a placing of 108,013,391 Ordinary Shares at 0.7 pence each. The funds aim to enhance exploration at Yarrol, Monal, and Mt Steadman, following the success in H1 2025. The placing requires shareholder approval at a General Meeting on 7 July 2025.

Contango HoldingsPLC - Board Changes

Board Changes at Contango Holdings PLC

Contango Holdings PLC has appointed Daniel Dos Santos as CEO, succeeding Carl Esprey, who will remain as an Executive Director for six months to ensure a seamless transition. Dos Santos brings extensive regional expertise, having previously worked on the Muchesu coal project and is set to advance the company's relationship with Huo Investments.

Mila Resources Plc - Conditional Subscription by a Director

Mila Resources PLC: Conditional Subscription by a Director

Mila Resources Plc has raised £20,000 via a subscription of 2,857,142 Ordinary Shares at 0.7 pence, involving director Mark Stephenson. His shareholding will increase to 20,073,903, conditional on resolutions at the General Meeting. Post-Admission on 8 July 2025, the company's total share capital will comprise 652,835,116 shares.

Upland Resources Ltd - Notice of 2025 Annual General Meeting (2025 AGM)

Upland Resources Limited: Notice of 2025 Annual General Meeting

Upland Resources Limited (LSE: UPL) announces that its 2025 Annual General Meeting (AGM) will occur at 4:00 pm BST on 28 July 2025 at Hill Dickinson LLP's offices, London. The Notice and Form of Proxy are being mailed and can be accessed via the company's website and the National Storage Mechanism.

AIM - Cancellation - Science in Sport plc

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM

Science in Sport PLC has announced the cancellation of its ordinary shares from trading on AIM, effective immediately. The company has requested this cancellation. For any inquiries or more information, please contact the company's nominated adviser. This announcement was made via RNS, the news service of the London Stock Exchange.

Angle PLC - EACR 2025: Innovation in AR expression profiling

ANGLE presents new data at EACR 2025 Highlighting Innovation in Androgen Receptor EXPRESSION profiling

ANGLE plc announced a poster presentation at EACR 2025 in Lisbon, showcasing a novel assay for androgen receptor expression in prostate cancer. Utilizing the Parsortix system, the assay demonstrates high sensitivity in monitoring drug response, highlighting potential for supporting AR-targeted clinical trials with longitudinal biomarker assessment.